Siemens forms molecular imaging division:
This article was originally published in Clinica
Executive Summary
Following its $1bn acquisition of CTI Molecular Imaging, Siemens has formed a new division called Siemens Medical Solutions Molecular Imaging. The business combines CTI's PET activities with Siemens' nuclear medicine business. It will be led by Michael Reitermann, hitherto president of Siemens Nuclear Medicine, while its chief scientific advisor will be by Dr Ronald Nutt, founder and former president and CEO of CTI Molecular Imaging.